Results: 24
Circ_0020123 plays an oncogenic role in non‐small cell lung cancer depending on the regulation of miR‐512‐3p/CORO1C.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 9, p. 1406, doi. 10.1111/1759-7714.14408
- By:
- Publication type:
- Article
Successful treatment of refractory brain metastases from ALK‐positive lung cancer with lorlatinib.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 9, p. 1431, doi. 10.1111/1759-7714.14406
- By:
- Publication type:
- Article
Postoperative bronchopleural fistula repair: Surgical outcomes and adverse factors for its success.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 9, p. 1401, doi. 10.1111/1759-7714.14404
- By:
- Publication type:
- Article
Effect of prior immunotherapy on the efficacy of chemotherapy in advanced non‐small cell lung cancer: A retrospective study.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 9, p. 1391, doi. 10.1111/1759-7714.14403
- By:
- Publication type:
- Article
Exosomal circDNER enhances paclitaxel resistance and tumorigenicity of lung cancer via targeting miR‐139‐5p/ITGB8.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 9, p. 1381, doi. 10.1111/1759-7714.14402
- By:
- Publication type:
- Article
Circ_ZFR affects FABP7 expression to regulate breast cancer progression by acting as a sponge for miR‐223‐3p.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 9, p. 1369, doi. 10.1111/1759-7714.14401
- By:
- Publication type:
- Article
Increased activation of cGAS‐STING pathway enhances radiosensitivity of non‐small cell lung cancer cells.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 9, p. 1361, doi. 10.1111/1759-7714.14400
- By:
- Publication type:
- Article
E2112—Does a negative phase III trial of endocrine therapy plus histone deacetylase inhibitor in hormone receptor‐positive advanced breast cancer represent a death knell?
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 9, p. 1237, doi. 10.1111/1759-7714.14399
- Publication type:
- Article
Association between clinical outcomes and local treatment in stage IV non‐small cell lung cancer patients with single extrathoracic metastasis.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 9, p. 1349, doi. 10.1111/1759-7714.14398
- By:
- Publication type:
- Article
Bevacizumab plus dacomitinib combination therapy for L858R‐mutated metastatic lung adenocarcinoma: A report of two cases.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 9, p. 1427, doi. 10.1111/1759-7714.14396
- By:
- Publication type:
- Article
Carboplatin plus nab‐paclitaxel for recurrent small cell lung cancer: A phase II study.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 9, p. 1342, doi. 10.1111/1759-7714.14394
- By:
- Publication type:
- Article
Intratumoral genetic and immune microenvironmental heterogeneity in T4N0M0 (diameter ≥ 7 cm) non‐small cell lung cancers.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 9, p. 1333, doi. 10.1111/1759-7714.14393
- By:
- Publication type:
- Article
Rapidly progressing metastatic malignant melanoma mimicking primary pleural tumor: A case report.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 9, p. 1423, doi. 10.1111/1759-7714.14392
- By:
- Publication type:
- Article
Cytokine release syndrome and successful response to pembrolizumab therapy in a patient with EGFR‐mutated non‐small‐cell lung cancer: A case report.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 9, p. 1419, doi. 10.1111/1759-7714.14390
- By:
- Publication type:
- Article
PD‐L1 expressed from tumor cells promotes tumor growth and invasion in lung cancer via modulating TGF‐β1/SMAD4 expression.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 9, p. 1322, doi. 10.1111/1759-7714.14388
- By:
- Publication type:
- Article
Heterogeneous nuclear ribonucleoprotein K promotes the progression of lung cancer by inhibiting the p53‐dependent signaling pathway.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 9, p. 1311, doi. 10.1111/1759-7714.14387
- By:
- Publication type:
- Article
Rare ashy dermatosis‐like hyperpigmentation associated with osimertinib.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 9, p. 1436, doi. 10.1111/1759-7714.14383
- Publication type:
- Article
Identification of a novel circ_0001946/miR‐1290/SOX6 ceRNA network in esophageal squamous cell cancer.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 9, p. 1299, doi. 10.1111/1759-7714.14381
- By:
- Publication type:
- Article
Establishment of prognostic nomograms for predicting the progression free survival of EGFR‐sensitizing mutation, advanced lung cancer patients treated with EGFR‐TKIs.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 9, p. 1289, doi. 10.1111/1759-7714.14380
- By:
- Publication type:
- Article
Circ_0011292 knockdown mitigates progression and drug resistance in PTX‐resistant non‐small‐cell lung cancer cells by regulating miR‐433‐3p/CHEK1 axis.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 9, p. 1276, doi. 10.1111/1759-7714.14378
- By:
- Publication type:
- Article
A phase II feasibility study of carboplatin and nab‐paclitaxel for advanced non‐small cell lung cancer patients with interstitial lung disease (YLOG0114).
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 9, p. 1267, doi. 10.1111/1759-7714.14376
- By:
- Publication type:
- Article
Postoperative venous thromboembolism after surgery for stage IA non‐small‐cell lung cancer: A single‐center, prospective cohort study.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 9, p. 1258, doi. 10.1111/1759-7714.14373
- By:
- Publication type:
- Article
A global perspective in second‐line treatment patterns for patients with advanced esophageal squamous cell carcinoma.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 9, p. 1240, doi. 10.1111/1759-7714.14334
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 9, p. 1235, doi. 10.1111/1759-7714.14023
- Publication type:
- Article